Early discontinuation of tamoxifen: a lesson for oncologists

Cancer. 2007 Dec 1;110(11):2595-6; author reply 2596. doi: 10.1002/cncr.23064.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antidepressive Agents / therapeutic use
  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Female
  • Fluoxetine / administration & dosage
  • Humans
  • Polypharmacy
  • Tamoxifen / therapeutic use*
  • Treatment Refusal*

Substances

  • Antidepressive Agents
  • Antineoplastic Agents, Hormonal
  • Fluoxetine
  • Tamoxifen